Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,741 | 719 | -1,830 | -1,074 | -92 |
| Depreciation Amortization | 1,883 | 962 | 4,035 | 3,058 | 2,088 |
| Income taxes - deferred | 119 | 35 | -2,441 | -1,712 | -1,301 |
| Accounts receivable | -294 | -437 | 436 | 948 | 265 |
| Accounts payable and accrued liabilities | 349 | -24 | -41 | -15 | 287 |
| Other Working Capital | -2,024 | -940 | 1,940 | 858 | -212 |
| Other Operating Activity | 712 | 757 | 1,961 | 748 | 345 |
| Operating Cash Flow | $2,486 | $1,072 | $4,060 | $2,811 | $1,380 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -666 | -169 | -1,556 | -1,023 | -582 |
| Net Acquisitions | N/A | N/A | 1,784 | 1,709 | N/A |
| Other Investing Activity | 0 | 0 | -57 | -57 | -57 |
| Investing Cash Flow | $-666 | $-169 | $171 | $629 | $-639 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 14,550 | 12,049 | 12,049 |
| Debt Repayment | -2,500 | -1,250 | N/A | -1,500 | -750 |
| Common Stock Issued | 1,001 | 319 | 3,621 | 2,290 | 1,999 |
| Other Financing Activity | 0 | 0 | -18,103 | -292 | 0 |
| Financing Cash Flow | $-1,499 | $-931 | $68 | $12,547 | $13,298 |
| Exchange Rate Effect | 342 | 94 | 791 | 263 | -622 |
| Beginning Cash Position | 25,771 | 25,771 | 20,681 | 20,681 | 20,681 |
| End Cash Position | 26,434 | 25,837 | 25,771 | 36,931 | 34,098 |
| Net Cash Flow | $663 | $66 | $5,090 | $16,250 | $13,417 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,486 | 1,072 | 4,060 | 2,811 | 1,380 |
| Capital Expenditure | -744 | -282 | -1,622 | -1,089 | -585 |
| Free Cash Flow | 1,742 | 790 | 2,438 | 1,722 | 795 |